Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-28

Clinical Trial Update: Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating aggressive fever control with intravenous ibuprofen after non-traumatic brain hemorrhage was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IV Ibuprofen (ibuprofen)

Snippet

Sponsor: Columbia University | Conditions: Fever | Phase 4 | Status: TERMINATED | Results posted: 2017-08-28